SNES (SNES) Stock Price & Analysis
SNES (SNES) fell 3.85% to USD 1 as of September 8, 2026 at 12:03 UTC, according to Nexqual real-time market data.
SNES last closed at USD 1; the session ranged USD 1–1.03 on volume of 24,138 shares. Market capitalization is —, with a 52-week range of USD 1–5.35 (NCM). Source: Nexqual, September 8, 2026 at 12:03 UTC.
Key Statistics (as of September 8, 2026 at 12:03 UTC)
| Price | USD 1 |
|---|---|
| Change | ▼ 3.85% (down) |
| Previous Close | USD 1 |
| Open | USD 1 |
| Day Range | USD 1 – 1.03 |
| 52-Week Range | USD 1 – 5.35 |
| Volume | 24,138 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (SNES)
Nexqual's technical model rates SNES "SELL" based on 1 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 12:03 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 30.05 (neutral) |
| vs SMA50 | Below (USD 1.32) |
| MACD | -0.09 (negative) |
From SNES's Latest SEC 10-K Filing (filed 2026-03-13)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SPCB | SuperCom, Ltd. | USD 9.92 | ▼ 3.22% |
| TENX | Tenax Therapeutics, Inc. | USD 1.94 | ▲ 4.86% |
| XMAX | XMAX, Inc. | USD 8.63 | ▼ 1.71% |
| SNOA | Sonoma Pharmaceuticals, Inc. | USD 1.33 | ▲ 2.71% |
| XBIO | Xenetic Biosciences, Inc. | USD 4.67 | ▲ 9.88% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 12:03 UTC. This page is informational and not investment advice.